

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 4.94474329 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.94474329 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.94474329 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.94474329 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.94474329 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.94474329 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 4.87803967 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78153103 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.72036227 |
| 10 | detection of other organism (GO:0098543) | 4.38667011 |
| 11 | response to peptidoglycan (GO:0032494) | 4.37409682 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.34926789 |
| 13 | detection of external biotic stimulus (GO:0098581) | 4.29536663 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.20167904 |
| 15 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15789138 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00600646 |
| 17 | detection of bacterium (GO:0016045) | 3.94000154 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.77838747 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77838747 |
| 20 | cellular extravasation (GO:0045123) | 3.77771994 |
| 21 | detection of biotic stimulus (GO:0009595) | 3.70615979 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 3.63359170 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.58598384 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.54264639 |
| 25 | neutrophil activation (GO:0042119) | 3.47841303 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43882233 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41716283 |
| 28 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.39543432 |
| 29 | macrophage activation (GO:0042116) | 3.39508617 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38983896 |
| 31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38867316 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.36127174 |
| 33 | granulocyte activation (GO:0036230) | 3.35877621 |
| 34 | microglial cell activation (GO:0001774) | 3.35829712 |
| 35 | response to host immune response (GO:0052572) | 3.32600046 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32600046 |
| 37 | positive regulation of leukocyte degranulation (GO:0043302) | 3.31077300 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28324875 |
| 39 | response to host (GO:0075136) | 3.28324875 |
| 40 | response to host defenses (GO:0052200) | 3.28324875 |
| 41 | glycosphingolipid catabolic process (GO:0046479) | 3.22384303 |
| 42 | positive regulation of mast cell degranulation (GO:0043306) | 3.21902049 |
| 43 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.21902049 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.13690495 |
| 45 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.12858248 |
| 46 | regulation of necroptotic process (GO:0060544) | 3.11044888 |
| 47 | oligosaccharide catabolic process (GO:0009313) | 3.09520713 |
| 48 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.08810134 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.08382707 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07609532 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.07185685 |
| 52 | neutrophil mediated immunity (GO:0002446) | 3.06334816 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.05948119 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04589234 |
| 55 | regulation of mast cell activation (GO:0033003) | 2.99623968 |
| 56 | glycolipid catabolic process (GO:0019377) | 2.99304090 |
| 57 | respiratory burst (GO:0045730) | 2.99128594 |
| 58 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97991837 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97694467 |
| 60 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.94688969 |
| 61 | germinal center formation (GO:0002467) | 2.91101012 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90374315 |
| 63 | hypotonic response (GO:0006971) | 2.90054705 |
| 64 | negative regulation of necroptotic process (GO:0060546) | 2.89576575 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.85596008 |
| 66 | negative regulation of interleukin-17 production (GO:0032700) | 2.84977250 |
| 67 | B cell mediated immunity (GO:0019724) | 2.83313256 |
| 68 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81384883 |
| 69 | leukocyte aggregation (GO:0070486) | 2.81028624 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80334480 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79378718 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77741982 |
| 73 | positive regulation of interferon-alpha production (GO:0032727) | 2.74657448 |
| 74 | regulation of necrotic cell death (GO:0010939) | 2.72250796 |
| 75 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.69506659 |
| 76 | membrane raft organization (GO:0031579) | 2.65065436 |
| 77 | positive regulation of regulated secretory pathway (GO:1903307) | 2.64531148 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64130198 |
| 79 | regulation of platelet aggregation (GO:0090330) | 2.63216371 |
| 80 | protein localization to endosome (GO:0036010) | 2.56225182 |
| 81 | regulation of interferon-alpha production (GO:0032647) | 2.55302697 |
| 82 | ceramide catabolic process (GO:0046514) | 2.54001565 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53509588 |
| 84 | myeloid leukocyte activation (GO:0002274) | 2.49792554 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.48888020 |
| 86 | regulation of interleukin-17 production (GO:0032660) | 2.47159883 |
| 87 | positive regulation of interleukin-6 production (GO:0032755) | 2.46295915 |
| 88 | neutrophil chemotaxis (GO:0030593) | 2.45763768 |
| 89 | hepatocyte apoptotic process (GO:0097284) | 2.45433814 |
| 90 | dendritic cell migration (GO:0036336) | 2.45057256 |
| 91 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.44972594 |
| 92 | I-kappaB phosphorylation (GO:0007252) | 2.44494218 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.43447028 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.43336492 |
| 95 | neutrophil migration (GO:1990266) | 2.42657579 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.39266190 |
| 97 | positive regulation of interferon-beta production (GO:0032728) | 2.38521091 |
| 98 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.37408619 |
| 99 | response to thyroid hormone (GO:0097066) | 2.36770937 |
| 100 | pinocytosis (GO:0006907) | 2.36613579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.84483986 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.01795506 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54825783 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.41891341 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.40448041 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24968257 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.10351453 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10335246 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02969281 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.99578270 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67276883 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66999049 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63225231 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.43319647 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41363691 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28532068 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23754616 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20891628 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.18879850 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17438970 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07136320 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97767322 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97699173 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96377241 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89359050 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86233425 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.85815882 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85330583 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81279673 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79269796 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78174362 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76503999 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69797243 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69740183 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64429273 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60400103 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53114896 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50943849 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50707579 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.49500196 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.47917802 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38930642 |
| 43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36951896 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36951896 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36495252 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36418728 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35698261 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35601575 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34801263 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34181516 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33193998 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31562245 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30383542 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29171229 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26349464 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26158454 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25910622 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25532085 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24967094 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24814758 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23332989 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20983370 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20679627 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19152826 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18893427 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18826622 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17712343 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17166079 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17030066 |
| 70 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16817731 |
| 71 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16346440 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16188944 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.14602129 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14443322 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13607716 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13156139 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12977319 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12786705 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12179185 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11495913 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11351273 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11098093 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11003691 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10551559 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10317574 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09844009 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08067880 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08013231 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07558492 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05142769 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04731001 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03905412 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03551215 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02681870 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01519950 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99338851 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97347277 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97040294 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96206517 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96053035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.52214397 |
| 2 | MP0005451_abnormal_body_composition | 3.25103019 |
| 3 | MP0003436_decreased_susceptibility_to | 3.02042132 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.99374491 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.71095268 |
| 6 | MP0002419_abnormal_innate_immunity | 2.49654437 |
| 7 | MP0003303_peritoneal_inflammation | 2.49021001 |
| 8 | MP0003828_pulmonary_edema | 2.44911376 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.34868198 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.23647849 |
| 11 | MP0009785_altered_susceptibility_to | 2.19936309 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.12606540 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.08251556 |
| 14 | MP0006082_CNS_inflammation | 2.05564976 |
| 15 | MP0009840_abnormal_foam_cell | 2.00048784 |
| 16 | MP0005025_abnormal_response_to | 1.98065959 |
| 17 | MP0005000_abnormal_immune_tolerance | 1.93100364 |
| 18 | MP0008260_abnormal_autophagy | 1.87964228 |
| 19 | MP0005671_abnormal_response_to | 1.86678351 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.84727051 |
| 21 | MP0004510_myositis | 1.83157376 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.81428093 |
| 23 | MP0002723_abnormal_immune_serum | 1.76518189 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.74667417 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.74488498 |
| 26 | MP0001800_abnormal_humoral_immune | 1.72096988 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.65222186 |
| 28 | MP0001819_abnormal_immune_cell | 1.64449513 |
| 29 | MP0005387_immune_system_phenotype | 1.63977508 |
| 30 | MP0001790_abnormal_immune_system | 1.63977508 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.63499916 |
| 32 | MP0004947_skin_inflammation | 1.62352422 |
| 33 | MP0003075_altered_response_to | 1.60920148 |
| 34 | MP0000685_abnormal_immune_system | 1.60808460 |
| 35 | MP0000343_altered_response_to | 1.56501078 |
| 36 | MP0005166_decreased_susceptibility_to | 1.56287071 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.56264713 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.54745884 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.53956032 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.53476109 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.49334569 |
| 42 | MP0000858_altered_metastatic_potential | 1.48050174 |
| 43 | MP0008469_abnormal_protein_level | 1.41281405 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.40672386 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.38282131 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.37636891 |
| 47 | MP0005164_abnormal_response_to | 1.36201575 |
| 48 | MP0002405_respiratory_system_inflammati | 1.32885205 |
| 49 | MP0004484_altered_response_of | 1.32754329 |
| 50 | MP0009764_decreased_sensitivity_to | 1.32148934 |
| 51 | MP0001853_heart_inflammation | 1.22891974 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.19748384 |
| 53 | MP0005165_increased_susceptibility_to | 1.18124360 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.17510891 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.17458730 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.17458730 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.16750332 |
| 58 | MP0002132_abnormal_respiratory_system | 1.16579302 |
| 59 | MP0000716_abnormal_immune_system | 1.15154855 |
| 60 | MP0003646_muscle_fatigue | 1.14598212 |
| 61 | MP0005360_urolithiasis | 1.13228865 |
| 62 | MP0002398_abnormal_bone_marrow | 1.11932248 |
| 63 | MP0008004_abnormal_stomach_pH | 1.11584906 |
| 64 | MP0003866_abnormal_defecation | 1.10016305 |
| 65 | MP0003763_abnormal_thymus_physiology | 1.09745716 |
| 66 | MP0000604_amyloidosis | 1.08552722 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 1.04511798 |
| 68 | MP0000749_muscle_degeneration | 1.00613246 |
| 69 | MP0002166_altered_tumor_susceptibility | 0.99738999 |
| 70 | MP0003045_fibrosis | 0.98777282 |
| 71 | MP0003448_altered_tumor_morphology | 0.98569358 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.97365669 |
| 73 | MP0002429_abnormal_blood_cell | 0.96862364 |
| 74 | MP0000689_abnormal_spleen_morphology | 0.96145321 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.95855816 |
| 76 | MP0002722_abnormal_immune_system | 0.94777361 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92885036 |
| 78 | MP0009763_increased_sensitivity_to | 0.90369679 |
| 79 | MP0004233_abnormal_muscle_weight | 0.89905016 |
| 80 | MP0000747_muscle_weakness | 0.89742226 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.89654936 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.89594589 |
| 83 | MP0005330_cardiomyopathy | 0.89380566 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.88871660 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.88457382 |
| 86 | MP0004883_abnormal_blood_vessel | 0.88017182 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.87779251 |
| 88 | MP0004130_abnormal_muscle_cell | 0.87069460 |
| 89 | MP0002006_tumorigenesis | 0.86277635 |
| 90 | MP0000609_abnormal_liver_physiology | 0.82770203 |
| 91 | MP0002269_muscular_atrophy | 0.82262328 |
| 92 | MP0003091_abnormal_cell_migration | 0.81289410 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.80369043 |
| 94 | MP0001851_eye_inflammation | 0.80322198 |
| 95 | MP0005365_abnormal_bile_salt | 0.79316054 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.77373275 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.77336825 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.77214365 |
| 99 | MP0002971_abnormal_brown_adipose | 0.77123360 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.77068154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.00222608 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.49286151 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.48681237 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.43826721 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.80045159 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63096645 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63096645 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63096645 |
| 9 | Myositis (HP:0100614) | 3.56500231 |
| 10 | Orchitis (HP:0100796) | 3.42480405 |
| 11 | Fatigue (HP:0012378) | 3.35041318 |
| 12 | Myocardial infarction (HP:0001658) | 3.33934926 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22695178 |
| 14 | Stomatitis (HP:0010280) | 3.22686575 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.15685328 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.05639341 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.01898502 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.01293727 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.95041407 |
| 20 | Optic neuritis (HP:0100653) | 2.95041407 |
| 21 | Amyloidosis (HP:0011034) | 2.95038724 |
| 22 | Obstructive lung disease (HP:0006536) | 2.94807084 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94807084 |
| 24 | Nemaline bodies (HP:0003798) | 2.93746647 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.92622293 |
| 26 | Chest pain (HP:0100749) | 2.90203215 |
| 27 | Recurrent skin infections (HP:0001581) | 2.82632873 |
| 28 | Urticaria (HP:0001025) | 2.82467214 |
| 29 | Gingivitis (HP:0000230) | 2.76708666 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.72622922 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.62778155 |
| 32 | Arterial thrombosis (HP:0004420) | 2.58534757 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.52031733 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 2.50109090 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.49118141 |
| 36 | Increased connective tissue (HP:0009025) | 2.47361984 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.44948959 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.39401738 |
| 39 | Loss of speech (HP:0002371) | 2.39261395 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29786954 |
| 41 | Gingival bleeding (HP:0000225) | 2.28265327 |
| 42 | Meningitis (HP:0001287) | 2.25948173 |
| 43 | Vasculitis (HP:0002633) | 2.23952668 |
| 44 | Osteomyelitis (HP:0002754) | 2.23689584 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.20679385 |
| 46 | Exercise-induced myalgia (HP:0003738) | 2.19424911 |
| 47 | Rhabdomyolysis (HP:0003201) | 2.15867315 |
| 48 | T lymphocytopenia (HP:0005403) | 2.15659352 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.13757794 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.13112400 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.12883810 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12702041 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12702041 |
| 54 | Hyporeflexia of lower limbs (HP:0002600) | 2.09084918 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.09006634 |
| 56 | Polycythemia (HP:0001901) | 2.08533753 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05307618 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.05307618 |
| 59 | Acute hepatic failure (HP:0006554) | 2.04749456 |
| 60 | Chronic diarrhea (HP:0002028) | 2.03731119 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03573273 |
| 62 | Pustule (HP:0200039) | 2.01518963 |
| 63 | Cellulitis (HP:0100658) | 1.98931899 |
| 64 | Epistaxis (HP:0000421) | 1.98220049 |
| 65 | Hemoptysis (HP:0002105) | 1.97884355 |
| 66 | Difficulty running (HP:0009046) | 1.97280742 |
| 67 | Malnutrition (HP:0004395) | 1.97253912 |
| 68 | Neck muscle weakness (HP:0000467) | 1.96815812 |
| 69 | Amaurosis fugax (HP:0100576) | 1.93397134 |
| 70 | Petechiae (HP:0000967) | 1.93361020 |
| 71 | Polyneuropathy (HP:0001271) | 1.92094398 |
| 72 | Anorexia (HP:0002039) | 1.90483308 |
| 73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89854431 |
| 74 | Toxemia of pregnancy (HP:0100603) | 1.89256921 |
| 75 | Keratoconjunctivitis (HP:0001096) | 1.88530364 |
| 76 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87473255 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 1.85920452 |
| 78 | Subacute progressive viral hepatitis (HP:0006572) | 1.85292420 |
| 79 | Encephalitis (HP:0002383) | 1.84490139 |
| 80 | Gangrene (HP:0100758) | 1.84166215 |
| 81 | Glomerulopathy (HP:0100820) | 1.83142721 |
| 82 | Increased serum ferritin (HP:0003281) | 1.82902182 |
| 83 | Increased IgE level (HP:0003212) | 1.81608949 |
| 84 | Disinhibition (HP:0000734) | 1.81029433 |
| 85 | Axonal loss (HP:0003447) | 1.78667890 |
| 86 | Increased CSF protein (HP:0002922) | 1.76362392 |
| 87 | Thrombocytosis (HP:0001894) | 1.75865818 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75629580 |
| 89 | Vertigo (HP:0002321) | 1.74955105 |
| 90 | Vertebral compression fractures (HP:0002953) | 1.74318389 |
| 91 | Peritonitis (HP:0002586) | 1.73846704 |
| 92 | Recurrent viral infections (HP:0004429) | 1.73623321 |
| 93 | Cerebral hemorrhage (HP:0001342) | 1.73012810 |
| 94 | Dysostosis multiplex (HP:0000943) | 1.72068242 |
| 95 | Myoglobinuria (HP:0002913) | 1.71211226 |
| 96 | Leukocytosis (HP:0001974) | 1.70930341 |
| 97 | Episodic fever (HP:0001954) | 1.68614589 |
| 98 | Abnormality of the endocardium (HP:0004306) | 1.67246997 |
| 99 | Upper motor neuron abnormality (HP:0002127) | 1.66953325 |
| 100 | Tetraparesis (HP:0002273) | 1.66792336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 2.84393348 |
| 2 | IRAK3 | 2.78281407 |
| 3 | MAP2K3 | 2.73327452 |
| 4 | MAP3K13 | 2.64899075 |
| 5 | MAP3K3 | 2.64431341 |
| 6 | BLK | 2.48681982 |
| 7 | ERN1 | 2.36025390 |
| 8 | MAP3K14 | 2.30315990 |
| 9 | CSK | 2.22160899 |
| 10 | IRAK4 | 2.20024957 |
| 11 | TTN | 2.19357608 |
| 12 | PRPF4B | 2.10528934 |
| 13 | MST1R | 2.10013883 |
| 14 | EPHB1 | 1.99340683 |
| 15 | ZAP70 | 1.87293047 |
| 16 | TYK2 | 1.87101846 |
| 17 | EPHA2 | 1.83732265 |
| 18 | BMPR2 | 1.80269440 |
| 19 | LMTK2 | 1.80106912 |
| 20 | MAP3K12 | 1.76702491 |
| 21 | MOS | 1.66236515 |
| 22 | PIK3CG | 1.65819920 |
| 23 | MAP3K2 | 1.60891298 |
| 24 | OBSCN | 1.57192761 |
| 25 | TAOK3 | 1.55671249 |
| 26 | JAK3 | 1.55328904 |
| 27 | KSR2 | 1.52432831 |
| 28 | TAOK2 | 1.52351030 |
| 29 | SIK3 | 1.48989110 |
| 30 | STK24 | 1.45453234 |
| 31 | TRPM7 | 1.43948003 |
| 32 | MAP3K1 | 1.40924013 |
| 33 | STK10 | 1.40627395 |
| 34 | TBK1 | 1.38556710 |
| 35 | PDK2 | 1.37427469 |
| 36 | MAP4K1 | 1.36996427 |
| 37 | NME2 | 1.22327104 |
| 38 | JAK1 | 1.19218892 |
| 39 | MST4 | 1.19111290 |
| 40 | TGFBR2 | 1.14246738 |
| 41 | FGR | 1.13420085 |
| 42 | GRK6 | 1.12195524 |
| 43 | BTK | 1.08972974 |
| 44 | HCK | 1.08899726 |
| 45 | PRKG2 | 1.08586163 |
| 46 | KSR1 | 1.05701073 |
| 47 | PAK4 | 1.02579306 |
| 48 | IRAK1 | 1.01348827 |
| 49 | TXK | 1.00612691 |
| 50 | JAK2 | 1.00566328 |
| 51 | FES | 0.95394142 |
| 52 | MARK3 | 0.94562128 |
| 53 | PDPK1 | 0.93131082 |
| 54 | TAOK1 | 0.90181623 |
| 55 | SYK | 0.89784040 |
| 56 | PDK1 | 0.88901548 |
| 57 | IRAK2 | 0.87631520 |
| 58 | ARAF | 0.84760372 |
| 59 | IKBKE | 0.84640883 |
| 60 | TESK2 | 0.82719490 |
| 61 | SCYL2 | 0.81585904 |
| 62 | IKBKB | 0.80875852 |
| 63 | GRK7 | 0.79011522 |
| 64 | MAP3K11 | 0.78134427 |
| 65 | ERBB4 | 0.77970019 |
| 66 | MATK | 0.76145032 |
| 67 | CSF1R | 0.75255570 |
| 68 | EIF2AK3 | 0.73229359 |
| 69 | RAF1 | 0.72213767 |
| 70 | YES1 | 0.70138944 |
| 71 | MAP3K6 | 0.68986764 |
| 72 | PHKG1 | 0.68951133 |
| 73 | PHKG2 | 0.68951133 |
| 74 | ITK | 0.68219031 |
| 75 | MAP3K5 | 0.67605950 |
| 76 | PTK6 | 0.66467359 |
| 77 | LYN | 0.65780290 |
| 78 | MAPK12 | 0.64528246 |
| 79 | DMPK | 0.63050219 |
| 80 | LCK | 0.60629729 |
| 81 | MAP3K8 | 0.58614597 |
| 82 | LRRK2 | 0.56577194 |
| 83 | TEC | 0.55259154 |
| 84 | MYLK | 0.51888180 |
| 85 | ABL2 | 0.50321765 |
| 86 | MAPKAPK2 | 0.50287339 |
| 87 | FGFR3 | 0.49995462 |
| 88 | MAP3K7 | 0.49035042 |
| 89 | ERBB3 | 0.48000449 |
| 90 | CAMKK2 | 0.47796741 |
| 91 | PTK2B | 0.46577749 |
| 92 | MAP2K6 | 0.46068226 |
| 93 | ACVR1B | 0.45646386 |
| 94 | SGK3 | 0.42505892 |
| 95 | MAP3K9 | 0.39558837 |
| 96 | PRKAA2 | 0.38682197 |
| 97 | NEK9 | 0.38488345 |
| 98 | WNK1 | 0.37090743 |
| 99 | TESK1 | 0.32812580 |
| 100 | MET | 0.27661516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24078535 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64794804 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59785516 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58279334 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.54458353 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51891816 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33435803 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.25379051 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.09188220 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.03025666 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02270269 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99920564 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97534304 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.92838436 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85423611 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.84164893 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.84145190 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.83422007 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.63613024 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63331944 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63316251 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60748613 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.59552154 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55810881 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.51406218 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49291767 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47819263 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40311605 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.32709005 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.28624154 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.27147306 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23124073 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.22119024 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19558003 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18828307 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15728391 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.15621054 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13906357 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12343081 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11652835 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.09218198 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08370163 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07083123 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05053661 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98744934 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98654337 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97965512 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97624254 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97434439 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94775443 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.91735028 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90285360 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.89758416 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.86988854 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.84705661 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84295991 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83371776 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.80515526 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79925286 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78298138 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73206192 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73044979 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71045700 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68762207 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67534267 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67408478 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65914940 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65597936 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64864806 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61474730 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59414825 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.57721310 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56551746 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.54405952 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.54316503 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52993527 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52219890 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51702560 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50931246 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50280334 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50210290 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.49286782 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49000728 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46643543 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46065143 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45858851 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44719001 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44211708 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43304733 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43058032 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41105574 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40394246 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39508629 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36592291 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34756026 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33408887 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33038021 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32547775 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31664527 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29523268 |

